Track record · closed signal

UiPath Inc. (PATH) — closed signal from December 4, 2025

Partial Published before the outcome was known, scored automatically when the window closed on March 4, 2026.

Predicted vs. what happened

PATH price · publication thesis → realized outcomesplit-adjusted
$17.07 Published $21.51 Target $11.07 Window close $19.84 Peak
$16.50 – $17.00Entry zone — fair-value band
$17.07Published — price the day we called it
$21.51Target — the price the thesis aimed for
$19.84Peak — highest point inside the window, not a realized return
$11.07Window close — end-of-window price, context only

What happened

Partial

Reached 62% of the predicted growth at its peak, without hitting the target.

Peak price
$19.84
peak on December 8, 2025 — not a realized return
Peak gain
+16.2%
peak, from the publication price
Window close
$11.07
end-of-window price, context only
Days to target
Window
December 4, 2025 – March 4, 2026

The thesis — published December 4, 2025

Predicted growth
+26%
over the measurement window
Target price
$21.51
the price the thesis aimed for
Entry zone
$16.50 – $17.00
the fair-value band we waited for
Price at publication
$17.07
published December 4, 2025
Confidence
78%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

UiPath surprised investors by reporting its first quarter with GAAP profit and stronger sales than expected. Management raised the next quarter sales forecast, so the stock jumped and became expensive in the short term. Buying immediately is risky; waiting for a pullback into the stated entry zone gives a clearer chance to benefit from growing automation demand and early profit progress.

Primary drivers

  • First GAAP profit shows the company is finally making money
  • Higher Q4 sales forecast confirms growing customer demand
  • Sharp price jump shows strong investor interest and attention
  • Adoption of RPA and AI is widening the company's customer reach

How it played out

PATH: target missed after early 16.2% peak

Lyra published PATH on 2025-12-04 at 17.07 with expected growth of 26%. The thesis pointed to UiPath's first GAAP profit, a higher Q4 sales forecast, strong investor attention after a sharp price jump, and wider customer reach from automation and artificial intelligence adoption. It also said buying immediately was risky and favored a pullback into 16.50 to 17.

Inside the window, PATH rose to 19.84 on 2025-12-08, a 16.2% peak gain. It stayed below the 21.51 target and never reached it. By 2026-03-04, it ended at 11.07. The thesis partially played out early, but the target missed.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.